[1]  仝艳, 郑志忠, 林毅, 明艳林. 非洲马铃果化学成分及其活性最新研究进展[J]. 亚热带植物科学, 2019, 48(4): 539–365.

[2]  Ding C F, Qin M L, Zhao K Y, Gao W, Yin S Z, Hu X G, Cheng G G, Zhang R P, Hu W Y. Voagafries A–E, undescribed indole alkaloids with anti-glioma activity from Voacanga africana [J]. Phytochemistry, 2025, 231: 114361.

[3]  康炼常, 林德钦, 郑志忠, 明艳林, 童庆宣. 非洲马铃果化学成分及其生物活性研究进展[J]. 中药材, 2012, 35(11): 1877–1881.

[4]  岳加蕊. 傣药宾蒿和非洲马铃果的化学成分研究[D]. 昆明: 云南中医学院硕士学位论文, 2013.

[5]  王荣, 李多伟. 高效液相色谱法测定不同方法提取非洲马铃果中的柳叶水甘草碱[J]. 中成药, 2012, 34(7): 1391–1393.

[6]  周晶, 刘佳佳, 吴义强, 袁广明. 非洲马铃果果籽提取物的体外抗肿瘤活性[J]. 亚热带植物科学, 2017, 46(2): 113–116.

[7]  La Barre J, Gillo L. Cardiotonic properties of a new alkaloid extract from Voacanga africana: voacaline [J]. C R Seances Soc Biol Fil, 1956, 150(8–9): 1628–1630.

[8]  陈红梅, 邓赟, 宋川霞, 戴宇, 胡佳, 康敏, 但小梅, 李鸿翔. 伏康树中单萜吲哚类生物碱及其NMR波谱特征[J]. 中国实验方剂学杂志, 2015, 21(7): 216–222.

[9]  Qin M, Li Y, Xu W, Gao W, Yin S, Hu X, Zhang R, Ding C. Spirooxindol alkaloids from Voacanga africana: Targeting biofilm of MBLs producing Escherichia coli [J]. Bioorganic Chemistry, 2023, 140: 106780.

[10]  Brunetti P, Lo Faro A F, Tini A, Busardo F P, Carlier J. Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects [J]. Pharmaceuticals (Basel, Switzerland), 2020, 13(10): 309.

[11] Dos Santos Torres Z E, Silveira E R, Rocha E Silva L F, Lima E S, De Vasconcellos M C, De Andrade Uchoa D E, Filho R B, Pohlit A M. Chemical composition of Aspidosperma ulei Markgr. and antiplasmodial activity of selected indole alkaloids [J]. Molecules, 2013, 18(6): 6281–6297.

[12]  Gunasekera S P, Badawi M M, Cordell G A, Farnsworth N R, Chitnis M. Plant anticancer agents X. Isolation of camptothecin and 9-methoxycamptothecin from Ervatamia heyneana [J]. Journal of Natural Products, 1979, 42(5): 475–477.

[13]  Carroll P R, Starmer G A. Studies on the pharmacology of conopharyngine, an indole alkaloid of the Voacanga series [J]. British Journal of Pharmacology and Chemotherapy, 1967, 30(1): 173–185.

[14]  Itoh A, Kumashiro T, Yamaguchi M, Nagakura N, Mizushina Y, Nishi T, Tanahashi T. Indole alkaloids and other constituents of Rauwolfia serpentina [J]. Journal of Natural Products, 2005, 68(6): 848–852.

[15]  Renner U, Prins D A. Voacanga alkaloids. IV. Structure of voacryptin and voacristine [J]. Experientia, 1961, 17: 106.

[16]  Janot M M, Goutarel R. Voacanga alkaloids: voacamine and vobtusine [J]. Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences, 1955, 240(17): 1719–1720.

[17]  Van Beek T A, Verpoorte R, Svendsen A B, Leeuwenberg A J, Bisset N G. Tabernaemontana L. (Apocynaceae): a review of its taxonomy, phytochemistry, ethnobotany and pharmacology [J]. Journal of Ethnopharmacology, 1984, 10(1): 1–156.

[18]  Mei L, Deng Y, Li F, Guo D L, Lu C Y. Study on the alkaloids constituents from Voacanga africana [J]. Journal of Chinese Medicinal Meterials, 2012, 35(2): 226–229.

[19]  Kitajima M, Iwai M, Kikura-Hanajiri R, Goda Y, Iida M, Yabushita H, Takayama H. Discovery of indole alkaloids with cannabinoid CB1 receptor antagonistic activity [J]. Bioorganic Medicinal Chemistry Letters, 2011, 21(7): 1962–1964.

[20]  Kombian S B, Saleh T M, Fiagbe N I, Chen X, Akabutu J J, Buolamwini J K, Pittman Q J. Ibogaine and a total alkaloidal extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro [J]. Brain Research Bulletin, 1997, 44(5): 603–610.

[21]  Oladeji O S, Odelade K A, Mahal A, Obaidullah A J, Zainul R. Systematic appraisals of naturally occurring alkaloids from medicinal plants [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397(10): 7439–7471.

[22]  Carreira E, Freis M. Total Synthesis of (+)-1,2- Dehydroaspidospermidine, (+)-Condyfoline, and (–)-Tubifoline [J]. Synfacts, 2020, 16(8): 0875.

[23]  Nugroho A E, Ono Y, Jin E, Hirasawa Y, Kaneda T, Rahman A, Kusumawati I, Tougan T, Horii T, Zaini N C, Morita H. Bisindole alkaloids from Voacanga grandifolia leaves [J]. Journal of Natural Medicines, 2021, 75(2): 408–414.

[24]  Chen H M, Yang Y T, Li H X, Cao Z X, Dan X M, Mei L, Guo D L, Song C X, Dai Y, Hu J, Deng Y. Cytotoxic monoterpenoid indole alkaloids isolated from the barks of Voacanga africana Staph [J]. Natural Product Research, 2016, 30(10): 1144–1149.

[25]  Furuya T, Sakamoto K, Iida K, Asada Y, Yoshikawa T, Sakai S, Aimi N. Biotransformation of tabersonine in cell suspension cultures of Catharanthus roseus [J]. Phytochemistry, 1992, 31(9): 3065–3068.

[26]  Musquiari B, Crevelin E J, Bertoni B W, Franca S C, Pereira A M S, Castello A C D, Castillo-Ordonez W O, Giuliatti S, Lopes A A. Precursor-directed biosynthesis in Tabernaemontana catharinensis as a new avenue for alzheimer's disease- modifying agents [J]. Planta Medica, 2021, 87(1–2): 136–147.

[27]  Coon A M, Musah R A. Investigation of small-molecule constituents in Voacanga africana seeds and mapping of their spatial distributions using laser ablation direct analysis in real-time imaging-mass spectrometry (LADI-MS) [J]. ACS Omega, 2023, 8(30): 27190–27205.

[28]  Stockigt J, Pawelka K H. Indole alkaloids from cell suspension cultures of Stemmadenia tomentosa and Voacanga africana [J]. Planta Med, 1982, 45(3): 155.

[29]  梅玲, 邓赟, 李甫, 郭大乐, 陆崇玉. 伏康树中生物碱化学成分研究 [J]. 中药材, 2012, 35(2): 226–229.

[30]  Renner U. Voacamidin and voacristin, two new alkaloids from Voacanga africana Stapf [J]. Experientia, 1957, 13(12): 468–469.

[31]  Harada M, Asaba K N, Iwai M, Kogure N, Kitajima M, Takayama H. Asymmetric total synthesis of an iboga-type indole alkaloid, voacangalactone, newly isolated from Voacanga africana [J]. Organic Letters, 2012, 14(22): 5800–5803.

[32]  Jenks C W. Extraction studies of Tabernanthe iboga and Voacanga africana [J]. Natural Product Letters, 2002, 16(1): 71–76.

[33]  Stöckigt J, Pawelka K H, Rother A, Deus B. Indole alkaloids from cell suspension cultures of Stemmadenia tomentosa and Voacanga africana [J]. Zeitschrift für Naturforschung C, 2015, 37(10): 857–860.

[34] Renner U, Prins D A. Voacanga alkaloids. V. Relationship of vobasine to dregamine and tabernaemontanine [J]. Experientia, 1961, 17: 209.

[35]  Oliver-Bever B. Medicinal plants in tropical west Africa. II. Plants acting on the nervous system [J]. Journal of Ethnopharmacology, 1983, 7(1): 1–93.

[36]  Kunesch N, Miet C, Troly M, Poisson J. Alkaloids of Voacanga. 8. Alkaloids of leaves and seeds of Voacanga africana Stapf]           [J]. French Pharmaceutical Annals, 1968, 26(1): 79–86.

[37]  Hussain H, Hussain J, Al-Harrasi A, Green I R. Chemistry and biology of the genus Voacanga [J]. Pharmaceutical Biology, 2012, 50(9): 1183–1193.

[38]  Qin M, Gao W, Wang H, Yin S, Hu J, Gao W, Ding C. Monoterpenoid indole alkaloids from the stem barks of Voacanga africana and their chemotaxonomic significance [J]. Biochemical Systematics and Ecology, 2024, 116: 104863–104863.

[39]  Shao S, Zhang H, Yuan C M, Zhang Y, Cao M M, Zhang H Y, Feng Y, Ding X, Zhou Q, Zhao Q, He H P, Hao X J. Cytotoxic indole alkaloids from the fruits of Melodinus cochinchinensis [J]. Phytochemistry, 2015, 116: 367–373.

[40]  Zhao Q, Zhu W T, Ding X, Huo Z Q, Donkor P O, Adelakun T A, Hao X J, Zhang Y. Voacafrines A–N, aspidosperma-type monoterpenoid indole alkaloids from Voacanga africana with AChE inhibitory activity [J]. Phytochemistry, 2021, 181: 112566.

[41]  Liu X, Yang D, Liu J, Ren N. Analysis of essential oils from Voacanga africana seeds at different hydrodistillation extraction stages: chemical composition, antioxidant activity and antimicrobial activity [J]. Natural Product Research, 2015, 29(20): 1950–1953.

[42]  Niu Y, Yang C, Zhou J, Huang S, Liu J. Two new compounds with antimicrobial activities from the seeds of Voacanga africana [J]. Phytochemistry Letters, 2016, 18: 208–212.

[43]  姜砚馨, 张惠, 费文婷, 王淳, 裴欢, 刘曦, 郭宝林, 王林元, 奥恰·巴尔纳巴斯, 夏立营, 张建军. 新外来中药非洲马铃果皮的药性研究 [J]. 世界中医药, 2024, 19(11): 1537–1543.

[44]  刘韶松, 童庆宣, 郑志忠, 陈良华, 康炼常, 郑远斌, 明艳林. 非洲马铃果种子的化学成分含量测定和生物活性研究 [J]. 亚热带植物科学, 2014, 43(2): 98–102.

[45]  De Jesus M S M, Macabeo A P G, Ramos J D A, De Leon V N O, Asamitsu K, Okamoto T. Voacanga globosa spirobisindole alkaloids exert antiviral activity in HIV latently infected cell lines by targeting the NF-kB Cascade: in vitro and in silico investigations [J]. Molecules, 2022, 27(3)：1138.

[46]  Bum E N, Taiwe G S, Nkainsa L A, Moto F C, Seke Etet P F, Hiana I R, Bailabar T, Rouyatou, Seyni P, Rakotonirina A, Rakotonirina S V. Validation of anticonvulsant and sedative activity of six medicinal plants [J]. Epilepsy & Behavior, 2009, 14(3): 454–458.

[47]  Wasko M J, Witt-Enderby P A, Surratt C K. DARK classics in chemical neuroscience: ibogaine [J]. ACS Chemical Neuroscience, 2018, 9(10): 2475–2483.

[48]  Yuko T, Syunji H, Hiromitsu T, Kunitoshi U, Makoto T, Tatsuo W. Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree [J]. Journal of Natural Products, 2014, 77(2): 285–297.

[49]  Diagne H S, Christophe M, Pascal S, Abdoulaye S, Bintou S F, Lydia K L G, Sylviane L. Treatment with bark extracts of Voacanga africana attenuates motor coordination deficit, depressive-like behavior and microglial reaction, in a mouse model of early Parkinson's disease [J]. Phytomedicine Plus, 2022, 2(3): 100285.

[50]  Zuo Y, Zhang C Z, Ren Q, Chen Y, Li X, Yang J R, Li H X, Tang W T, Ho H M, Sun C, Li M M, Ren B, Deng Y, Wang M L, Lu J. Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway by voacamine suppress breast cancer progression [J]. Phytomedicine, 2022, 99: 154015.

[51]  Xiao F, Hou J, Fang D, Yang W, Li C. Anticancer activity of voacangine against human oral cancer cells is due to G2/M cell cycle arrest, ROS-mediated cell death and inhibition of PI3K/AKT signalling pathway [J]. Journal of BUON, 2020, 25(4): 2023–2027.

[52]  Ohishi K, Toume K, Arai M A, Sadhu S K, Ahmed F, Ishibashi M. Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing beta-catenin mRNA expression [J]. Bioorganic & Medicinal Chemistry Letters, 2015, 25(18): 3937–3940.

[53]  Condello M, Pellegrini E, Multari G, Gallo F R, Meschini S. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance [J]. Toxicology in Vitro, 2020, 65: 104819.

[54]  Meschini S, Condello M, Marra M, Formisano G, Federici E, Arancia G. Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells [J]. Toxicology in Vitro, 2007, 21(2): 197–203.

[55]  Yao C, Jirui Y, Yi Z, Chaozheng Z, Yiru P, Qing R, Xiao L, Yunqian H, Hui H, Huan Y, Ouyang Y, Xila X, Aiping L, Sanjun S, Yun D, Jun L. Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway [J]. Pharmacological Research, 2022, 184: 106415–106415.

[56]  Olivier D K, Wyk B E V. Bitterness values for traditional tonic plants of southern Africa [J]. Journal of Ethnopharmacology, 2013, 147(3): 676–679.

[57]  Igbe I, Silvanus I, Stephen V O, Lucy A. Chronic Toxicity studies of aqueous leaf extract of Voacanga africana in Wistar rats [J]. Journal of Applied Sciences and Environmental Management, 2016, 19(4): 639–639.

[58]  Olaleye S, Oke J, Etu A, Omotosho I, Elegbe R. Antioxidant and anti inflammatory properties of a flavonoid fraction from the leaves of Voacanga africana [J]. Nigerian Journal of Physiological Sciences, 2004, 19(1): 69–76.

[59]  Tan P V, Nyasse B. Anti-ulcer compound from Voacanga africana with possible histamine H2 receptor blocking activity [J]. Phytomedicine, 2000, 7(6): 509–515.

[60]  Tan P V, Penlap V B, Nyasse B, Nguemo J D B. Anti-ulcer actions of the bark methanol extract of Voacanga africana in different experimental ulcer models in rats [J]. Journal of Ethnopharmacology, 2000, 73(3): 423–428.

[61]  Wang Y Q, Li H X, Liu X C, Zhao J S, Liu R Q, Huai W Y, Ding W J, Zhang T E, Deng Y. One bis-indole alkaloid- voacamine from Voacanga africana Stapf: biological activity evaluation of PTP1B in vitro utilizing enzymology method based on SPRi expriment [J]. Natural Product Research, 2019, 33(23): 3459–3463.

[62]  Awah L A, Taïwe G S, Babiaka S B, Ngwa F C, Ngemenya M N. In vivo antibacterial activity of the methanol extract of Voacanga africana Stapf (Apocynaceae) stem bark against clinical multidrug-resistant Salmonella Typhimurium in Wistar rats [J]. Scientific African, 2024, 23: e02118.

[63]  Mair, Carolina d M S, Ulrike G, M K J, Fernando C, Sonego Z E, Verlindo d A B, Teresa D C, M R J. Pharmacokinetics of hERG Channel Blocking Voacangine in Wistar Rats Applying a Validated LC-ESI-MS/MS Method [J]. Planta medica, 2016, 82(11–12): 1030–1038.

[64]  Oppong B E, Amene O J A, Michael L, Patrick A. Ethnomedicinal uses, biological activities, and toxicity of Voacanga africana Stapf Ex Scott-Elliot [J]. Advances in Traditional Medicine, 2023, 24(2): 431–448.

[65]  白雅竹, 郑志忠, 陈清智, 黄雯, 陈良华, 林河通, 明艳林. 非洲马铃果4种吲哚类生物碱的体外抗肿瘤效果 [J]. 亚热带植物科学, 2019, 48(3): 209–214.

[66]  Chen H M, Yang Y T, Li H X, Cao Z X, Dan X M, Mei L, Guo D L, Song C X, Dai Y, Hu J, Deng Y. Cytotoxic monoterpenoid indole alkaloids isolated from the barks of Voacanga africana Staph [J]. Natural Product Research, 2016, 30(10): 1144–1149.